Home / Donepezil and Memantine / United States
US ATC N06DA52 · updated 2 Nov 2026
Donepezil and Memantine shortage in United States
Is there a Donepezil and Memantine shortage in United States?
Yes. As of 2 Nov 2026, 2 Donepezil and Memantine products are reported short in United States, the first since 15 Jun 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3) discontinuation | Amneal Pharmaceuticals | 15 Jun 2026 | not given | Not stated |
| US | Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3) discontinuation | Amneal Pharmaceuticals | 15 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).